Skip Navigation

European Heart Journal 1993 14(12):1701-1708;
Copyright © 1993 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by MUIESAN, M. L.
Right arrow Articles by AGABITI-ROSEI, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MUIESAN, M. L.
Right arrow Articles by AGABITI-ROSEI, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1993 The Europen Society of Cardiology

Effects of transdermal nitroglycerin in combination with an ACE inhibitor in patients with chronic stable angina pectoris

M. L. MUIESAN, E. BONI, M. CASTELLANO, M. BESCHI, G. CEFIS*, B. CERRI*, P. VERDECCHIA{dagger}, C. PORCELLATI{dagger}, G. POLLAVINI and E. AGABITI-ROSEI

Chair of Internal Medicine, University of Brescia Brescia, Italy
*Cardiovascular Rehabilitation Fasano (Brescia), Italy
{dagger}Internal Medicine Department Citta' della Pieve (Perugia), Italy

Received 7 December 1992; revised 17 May 1993; .

Correspondence Maria Lorenza Muiesan, Chair of Internal Medicine University of Brescia, c/o la Medicina generale-Spedali Civili, 25100 Brescia, Italy

Abstract

We have previously shown that transdermal nitroglycerin may induce an increase in the activity of the adrenergic and the renin-angiotensin-aldosterone systems (SRAA) in patients with chronic stable angina pectoris (SA); when the activation of these systems is more pronounced, the antianginal effect of this drug seems to be reduced. The aim of this study was to evaluate the antianginal efficacy of transdermal nitroglycerin administration (TTS-NG 10 mg. 24 h–1) in combination with an ACE inhibitor without sulphydryl groups (BNZ, benazepril 10 mg b.i.d.) in respect to placebo, or to TTS-NG or BNZ administered as monotherapy. Twenty-four patients (21M, 3F) were admitted to this multicentre, randomized, double-blind, latin square, placebo-controlled study. Patients received all the treatments (placebo, TTS-NG, BNZ and BNZ+ TTS-NG) each for one week; at the end of each week patients performed two exercise testi 2 and 22 h post-dosing. Two hours post-dosing, exercise duration at 1 mm ST depression was significantly increased in respect to placebo during TTS-NG (P<0.05) and TTS-NG+BNZ (P<0.05) treatments. Two hours post-dosing, exercise duration at peak exercise was also increased in respect to placebo during TTS-NG (P<0.05) ana TTS-NG+BNZ (P<0.05); 22 h post-dosing the increase in exercise duration was significant only during TTS-NG+BNZ treatment (P<0.05) in respect to placebo, but not during TTS-NG given alone. Rate-pressure product at 1 mm ST depression was significantly increased 2 h post-dosing during TTS-NG treatment (P<005).

In conclusion, these results suggest that ACE inhibitor administration given in combination with TTS-NG can induce a statistically significant increase in exercise duration in stable angina patients in respect of placebo, 22 h post-dosing. The clinical significance of this finding must be evaluated in further studies.

Key Words: Stable angina pectoris • ACE inhibitors • nitrates • exercise tolerance


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
D. Hebert and J. Y. T. Lam
Nitroglycerin rebound associated with vascular, rather than platelet, hypersensitivity
J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2311 - 2316.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Kurz, U. Hink, G. Nickenig, A. B. Borthayre, D. G. Harrison, and T. Munzel
Evidence for a Causal Role of the Renin-Angiotensin System in Nitrate Tolerance
Circulation, June 22, 1999; 99(24): 3181 - 3187.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Watanabe, M. Kakihana, S. Ohtsuka, and Y. Sugishita
Randomized, Double-Blind, Placebo-Controlled Study of Ascorbate on the Preventive Effect of Nitrate Tolerance in Patients With Congestive Heart Failure
Circulation, March 10, 1998; 97(9): 886 - 891.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. D. Parker and J. O. Parker
Nitrate Therapy for Stable Angina Pectoris
N. Engl. J. Med., February 19, 1998; 338(8): 520 - 531.
[Full Text] [PDF]


Home page
CirculationHome page
H. Watanabe, M. Kakihana, S. Ohtsuka, and Y. Sugishita
Randomized, Double-Blind, Placebo-Controlled Study of Supplemental Vitamin E on Attenuation of the Development of Nitrate Tolerance
Circulation, October 21, 1997; 96(8): 2545 - 2550.
[Abstract] [Full Text]


Home page
CirculationHome page
T. Munzel and E. Bassenge
Long-term Angiotensin-Converting Enzyme Inhibition With High-Dose Enalapril Retards Nitrate Tolerance in Large Epicardial Arteries and Prevents Rebound Coronary Vasoconstriction In Vivo
Circulation, June 1, 1996; 93(11): 2052 - 2058.
[Abstract] [Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.